Lange, Lara M.Avenali, MicolEllis, MelinaIllarionova, AnastasiaKeller Sarmiento, Ignacio J.Tan, Ai-HueyMadoev, HarutyunGalandra, CaterinaJunker, JohannaRoopnarain, KarishaSolle, JustinWegel, ClaireFang, Zih-HuaHeutink, PeterKumar, Kishore R.Lim, Shen-YangValente, Enza MariaNalls, MikeBlauwendraat, CornelisSingleton, AndrewMencacci, NiccoloLohmann, KatjaKlein, ChristineGlobal Parkinson’s Genetic Program (GP2)2024-01-252024-01-252023-06-27Lange LM, Avenali M, Ellis M, et al. Elucidating causative gene variants in hereditary Parkinson's disease in the Global Parkinson's Genetics Program (GP2) [published correction appears in NPJ Parkinsons Dis. 2023 Sep 13;9(1):133]. NPJ Parkinsons Dis. 2023;9(1):100. Published 2023 Jun 27. doi:10.1038/s41531-023-00526-9https://hdl.handle.net/1805/38197The Monogenic Network of the Global Parkinson’s Genetics Program (GP2) aims to create an efficient infrastructure to accelerate the identification of novel genetic causes of Parkinson’s disease (PD) and to improve our understanding of already identified genetic causes, such as reduced penetrance and variable clinical expressivity of known disease-causing variants. We aim to perform short- and long-read whole-genome sequencing for up to 10,000 patients with parkinsonism. Important features of this project are global involvement and focusing on historically underrepresented populations.en-USAttribution 4.0 InternationalSequencingParkinson's diseaseArticle